Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway
- 31 December 2003
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 126 (6) , 1892-1899
- https://doi.org/10.1016/j.jtcvs.2003.08.012
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- TAT Protein Transduction Into Isolated Perfused HeartsCirculation, 2002
- Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Mitochondria, the killer organelles and their weaponsJournal of Cellular Physiology, 2002
- Losing heart: the role of apoptosis in heart disease—a novel therapeutic target?The FASEB Journal, 2001
- The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventionsCardiovascular Research, 1999
- Myocardial infarction, ventricular remodeling, and angiotensin-converting enzyme inhibition: where we stand today.American Heart Journal, 1998
- Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase InhibitorCirculation, 1998
- Apoptosis in Human Acute Myocardial InfarctionCirculation, 1997
- Reperfusion injury induces apoptosis in rabbit cardiomyocytes.Journal of Clinical Investigation, 1994